KLK3 and Familial prostate cancer: Given that the interpretation on the results of meta-analyses was complicated by interstudy heterogeneity, Wu et al. recently reported the data from a 24-year prospective cohort study (n = 47,885), which suggests that higher intake of ALA is not associated with the lethal prostate cancer risk after the introduction of PSA screening (Wu et al., 2018).